• Issue

    Hepatology: Volume 43, Issue 3

    383-639
    March 2006
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Hepatology Highlights

Free Access

Hepatology highlights†

Elwyn Elias, 
  • Pages: 383-384
  • First Published: 22 February 2006

Perspectives in Clinical Hepatology

Free Access

The use of vasoconstrictors in patients with cirrhosis: Type 1 HRS and beyond

Richard Moreau,  Didier Lebrec, 
  • Pages: 385-394
  • First Published: 22 February 2006

Editorial

Free Access

NK cells: Natural born killers in the conflict between humans and HCV†‡

Margaret James Koziel M.D., 
  • Pages: 395-397
  • First Published: 22 February 2006
Free Access

Polluting the pathogenesis of primary biliary cirrhosis†‡

Jayant A. Talwalkar M.D., M.P.H.,  Konstantinos N. Lazaridis M.D., 
  • Pages: 398-400
  • First Published: 22 February 2006
Free Access

Hepatic adenomas: Presumed innocent until proven to be beta-catenin mutated†‡

Satdarshan P. S. Monga M.D., 
  • Pages: 401-404
  • First Published: 22 February 2006
Free Access

Wedged hepatic vein pressure (WHVP): Ready for prime time†‡

Thomas D. Boyer M.D., 
  • Pages: 405-406
  • First Published: 22 February 2006

Liver Biology and Pathobiology

Biology

Free Access

Zonal gene expression in murine liver: Lessons from tumors†

Stephan Hailfinger,  Maike Jaworski,  Albert Braeuning,  Albrecht Buchmann,  Michael Schwarz, 
  • Pages: 407-414
  • First Published: 22 February 2006

Pathobiology

Free Access

Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of β-catenin†

Zhaorui Lian,  Jie Liu,  Li Li,  Xianxing Li,  Marcy Clayton,  Meng-Chao Wu,  Hong-Yang Wang,  Patrick Arbuthnot,  Michael Kew,  Daiming Fan,  Mark A. Feitelson, 
  • Pages: 415-424
  • First Published: 22 February 2006
Free Access

HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL†

Anita Pathil,  Sorin Armeanu,  Sascha Venturelli,  Paolo Mascagni,  Thomas S. Weiss,  Michael Gregor,  Ulrich M. Lauer,  Michael Bitzer, 
  • Pages: 425-434
  • First Published: 22 February 2006
Free Access

Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo†

Shan-Shan Zhan,  Joy X. Jiang,  Jian Wu,  Charles Halsted,  Scott L. Friedman,  Mark A. Zern,  Natalie J. Torok, 
  • Pages: 435-443
  • First Published: 22 February 2006
Free Access

Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligation†

M. Salud García-Ayllón,  M. Ximena Silveyra,  Asunción Candela,  Antonio Compañ,  Joan Clària,  Rodrigo Jover,  Miguel Pérez-Mateo,  Vicente Felipo,  Salvador Martínez,  Joan Galcerán,  Javier Sáez-Valero, 
  • Pages: 444-453
  • First Published: 22 February 2006
Free Access

Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver†

Claudia Zwingmann,  Marc Bilodeau, 
  • Pages: 454-463
  • First Published: 22 February 2006
Free Access

Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival†

Takashi Kaizu,  Atsushi Ikeda,  Atsunori Nakao,  Yoshihito Takahashi,  Allan Tsung,  Junichi Kohmoto,  Hideyoshi Toyokawa,  Lifang Shao,  Brian T. Bucher,  Koji Tomiyama,  Michael A. Nalesnik,  Noriko Murase,  David A. Geller, 
  • Pages: 464-473
  • First Published: 22 February 2006
Free Access

Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair†

Xiaoling Jin,  Teresa A. Zimmers,  Eduardo A. Perez,  Robert H. Pierce,  Zongxiu Zhang,  Leonidas G. Koniaris, 
  • Pages: 474-484
  • First Published: 22 February 2006

Liver Failure and Liver Disease

Liver Failure

Free Access

Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension†

Manuel Hernández-Guerra,  Juan C. García-Pagán,  Juan Turnes,  Pablo Bellot,  Ramón Deulofeu,  Juan G. Abraldes,  Jaime Bosch, 
  • Pages: 485-491
  • First Published: 22 February 2006
Free Access

Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation†

Alejandro Blasco,  Xavier Forns,  José A. Carrión,  Juan Carlos García-Pagán,  Rosa Gilabert,  Antoni Rimola,  Rosa Miquel,  Miquel Bruguera,  Juan-Carlos García-Valdecasas,  Jaime Bosch,  Miquel Navasa, 
  • Pages: 492-499
  • First Published: 22 February 2006
Free Access

Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002†

Knut Stokkeland,  Lena Brandt,  Anders Ekbom,  Rolf Hultcrantz, 
  • Pages: 500-505
  • First Published: 22 February 2006

Liver Disease

Free Access

Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: Impact on disease progression†‡

Yoshihiro Ikura,  Masahiko Ohsawa,  Takehisa Suekane,  Hiroko Fukushima,  Hiroyuki Itabe,  Hisato Jomura,  Shuhei Nishiguchi,  Takeshi Inoue,  Takahiko Naruko,  Shoichi Ehara,  Norifumi Kawada,  Tetsuo Arakawa,  Makiko Ueda, 
  • Pages: 506-514
  • First Published: 22 February 2006
Free Access

Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC†‡

Jessica Zucman-Rossi,  Emmanuelle Jeannot,  Jeanne Tran Van Nhieu,  Jean-Yves Scoazec,  Catherine Guettier,  Sandra Rebouissou,  Yannick Bacq,  Emmanuelle Leteurtre,  Valérie Paradis,  Sophie Michalak,  Dominique Wendum,  Laurence Chiche,  Monique Fabre,  Lucille Mellottee,  Christophe Laurent,  Christian Partensky,  Denis Castaing,  Elie Serge Zafrani,  Pierre Laurent-Puig,  Charles Balabaud,  Paulette Bioulac-Sage, 
  • Pages: 515-524
  • First Published: 22 February 2006
Free Access

Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites†‡

Aftab Ala,  Carmen M. Stanca,  Moueen Bu-Ghanim,  Imad Ahmado,  Andrea D. Branch,  Thomas D. Schiano,  Joseph A. Odin,  Nancy Bach, 
  • Pages: 525-531
  • First Published: 22 February 2006
Free Access

Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly†‡

Albert J. Czaja,  Herschel A. Carpenter, 
  • Pages: 532-538
  • First Published: 22 February 2006

Viral Hepatitis

Free Access

Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection†

Andreas Untergasser,  Uta Zedler,  Anja Langenkamp,  Marianna Hösel,  Maria Quasdorff,  Knud Esser,  Hans-Peter Dienes,  Barbara Tappertzhofen,  Waldemar Kolanus,  Ulrike Protzer, 
  • Pages: 539-547
  • First Published: 22 February 2006
Free Access

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients†

Yves Benhamou,  Herve Fleury,  Pascale Trimoulet,  Isabelle Pellegrin,  Renaud Urbinelli,  Christine Katlama,  Willy Rozenbaum,  Gwenael Le Teuff,  Aldo Trylesinski,  Christophe Piketty, 
  • Pages: 548-555
  • First Published: 22 February 2006
Free Access

Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29-year longitudinal study†

Flavia Bortolotti,  Maria Guido,  Samuela Bartolacci,  Paolo Cadrobbi,  Carlo Crivellaro,  Franco Noventa,  Giulia Morsica,  Maria Moriondo,  Angelo Gatta, 
  • Pages: 556-562
  • First Published: 22 February 2006
Free Access

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution†

Christoph Neumann-Haefelin,  Susan McKiernan,  Scott Ward,  Sergei Viazov,  Hans Christian Spangenberg,  Thomas Killinger,  Thomas F. Baumert,  Natalja Nazarova,  Isabelle Sheridan,  Oliver Pybus,  Fritz von Weizsäcker,  Michael Roggendorf,  Dermot Kelleher,  Paul Klenerman,  Hubert E. Blum,  Robert Thimme, 
  • Pages: 563-572
  • First Published: 22 February 2006
Free Access

Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing†‡

Chihiro Morishima,  Denise M. Paschal,  Chia C. Wang,  Christina S. Yoshihara,  Brent L. Wood,  Anthony E. T. Yeo,  Scott S. Emerson,  Margaret C. Shuhart,  David R. Gretch, 
  • Pages: 573-580
  • First Published: 22 February 2006
Free Access

Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity†

Gary A. Levy,  Gord Adamson,  M. James Phillips,  Louise A. Scrocchi,  Laisum Fung,  Pieter Biessels,  Nancy F. Ng,  Anand Ghanekar,  Andrea Rowe,  Max Xuezhong Ma,  Adam Levy,  Cheryl Koscik,  William He,  Reginald Gorczynski,  Steve Brookes,  Caroline Woods,  Ian D. McGilvray,  David Bell, 
  • Pages: 581-591
  • First Published: 22 February 2006
Free Access

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33†

Alexander W. Tarr,  Ania M. Owsianka,  Judith M. Timms,  C. Patrick McClure,  Richard J. P. Brown,  Timothy P. Hickling,  Thomas Pietschmann,  Ralf Bartenschlager,  Arvind H. Patel,  Jonathan K. Ball, 
  • Pages: 592-601
  • First Published: 22 February 2006
Free Access

The influence of T cell cross-reactivity on HCV-peptide specific human T cell response†‡

Patrick T.F. Kennedy,  Simonetta Urbani,  Rebecca A. Moses,  Barbara Amadei,  Paola Fisicaro,  Jilly Lloyd,  Mala K. Maini,  Geoffrey Dusheiko,  Carlo Ferrari,  Antonio Bertoletti, 
  • Pages: 602-611
  • First Published: 22 February 2006

Hepatology Elsewhere

Free Access

A novel function for a micro RNA: Negative regulators can do positive for the hepatitis C virus†

Nicole Appel Ph.D.,  Ralf Bartenschlager Ph.D., 
  • Pages: 612-615
  • First Published: 22 February 2006
Free Access

Cardif: A protein central to innate immunity is inactivated by the HCV NS3 serine protease†

Jared D. Evans Ph.D.,  Christoph Seeger Ph.D., 
  • Pages: 615-617
  • First Published: 22 February 2006

Special Article

Free Access

Drug-induced liver injury: Summary of a single topic clinical research conference†

Paul B. Watkins,  Leonard B. Seeff, 
  • Pages: 618-631
  • First Published: 22 February 2006

Correspondence

Free Access

Methotrexate for treatment of primary biliary cirrhosis†

Peter A Bonis M.D.,  Marshall Kaplan M.D., 
  • Page: 632
  • First Published: 22 February 2006
Free Access

Reply†

Burton Combes M.D.,  Scott S. Emerson M.D., Ph.D., 
  • Pages: 632-633
  • First Published: 22 February 2006
Free Access

Reflections on therapeutic trials in primary biliary cirrhosis: A quality of life oriented counter-view†

David E.J. Jones,  Neeraj Bhala,  Julia L. Newton, 
  • Page: 633
  • First Published: 22 February 2006
Free Access

Reply†

Burton Combes M.D., 
  • Page: 634
  • First Published: 22 February 2006

Landmarks

Free Access

True, true … but are they related?†

Adrian Reuben MBBS, FRCP, 
  • Pages: 635-639
  • First Published: 22 February 2006